Cargando…

Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling

Oridonin, a bioactive diterpenoid isolated from Rabdosia rubescens, has been reported to exert anticancer activity in various cancers. However, the molecular mechanism of oridonin in thyroid cancer has not yet been elucidated. In the present study, oridonin was found to significantly inhibit migrati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wei, Wang, Xindi, Wang, Le, Mei, Yu, Yun, Yanning, Yao, Xiaobao, Chen, Qian, Zhou, Jinsong, Kou, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254367/ https://www.ncbi.nlm.nih.gov/pubmed/35813296 http://dx.doi.org/10.7150/ijms.70733

Ejemplares similares

Oridonin inhibits VEGF-A-associated angiogenesis and epithelial-mesenchymal transition of breast cancer in vitro and in vivo
por: Li, Chunyu, et al.
Publicado: (2018)

Oridonin inhibits epithelial-mesenchymal transition of human nasopharyngeal carcinoma cells by negatively regulating AKT/STAT3 signaling pathway
por: Liu, Wei, et al.
Publicado: (2021)

Galangin inhibits epithelial-mesenchymal transition and angiogenesis by downregulating CD44 in glioma
por: Chen, Daliang, et al.
Publicado: (2019)

The Jak/Stat Signaling Pathway Is Downregulated at Febrile Temperatures
por: Nespital, Tobias, et al.
Publicado: (2012)

Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression
por: Wu, Bingshan, et al.
Publicado: (2021)

GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma
por: Gao, Haoji, et al.
Publicado: (2022)

Salinomycin repressed the epithelial–mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway
por: Li, Rui, et al.
Publicado: (2017)

Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway
por: Liu, Qian-Qian, et al.
Publicado: (2016)

Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma
por: Lee, Jong Hyun, et al.
Publicado: (2020)

ANXA1 enhances tumor proliferation and migration by regulating epithelial-mesenchymal transition and IL-6/JAK2/STAT3 pathway in papillary thyroid carcinoma
por: Zhao, Xin, et al.
Publicado: (2021)

STEAP1 facilitates metastasis and epithelial–mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway
por: Huo, Shu-fen, et al.
Publicado: (2020)

Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial–Mesenchymal Transition
por: Jin, Wook
Publicado: (2020)

Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling
por: Wu, Anbiao, et al.
Publicado: (2022)

Oridonin inhibits tumor angiogenesis and induces vessel normalization in experimental colon cancer
por: Zhou, Jing, et al.
Publicado: (2021)

Nitidine chloride suppresses epithelial‐mesenchymal transition and stem cell‐like properties in glioblastoma by regulating JAK2/STAT3 signaling
por: Jia, Mingbo, et al.
Publicado: (2021)

Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1/STAT3 signaling pathway
por: Chen, Xiaoyun, et al.
Publicado: (2020)

WNT5A drives interleukin-6-dependent epithelial–mesenchymal transition via the JAK/STAT pathway in keloid pathogenesis
por: Lee, Young In, et al.
Publicado: (2022)

STAT3 and epithelial–mesenchymal transitions in carcinomas
por: Wendt, Michael K, et al.
Publicado: (2014)

Oridonin Inhibits Tumor Growth and Metastasis through Anti-Angiogenesis by Blocking the Notch Signaling
por: Dong, Yanmin, et al.
Publicado: (2014)

Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
por: Di Benedetto, Paola, et al.
Publicado: (2021)

Antiangiogenic effects of oridonin
por: Tian, Lili, et al.
Publicado: (2017)

Loss of TET2 impairs endothelial angiogenesis via downregulating STAT3 target genes
por: Shi, Yefei, et al.
Publicado: (2023)

Oridonin inhibits the migration and epithelial‐to‐mesenchymal transition of small cell lung cancer cells by suppressing FAK‐ERK1/2 signalling pathway
por: Xu, Linhao, et al.
Publicado: (2020)

Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway
por: Sui, Yan-Bo, et al.
Publicado: (2019)

Mechanisms of JAK-STAT signaling pathway mediated by CXCL8 gene silencing on epithelial-mesenchymal transition of human cutaneous melanoma cells
por: Hu, Xiaorui, et al.
Publicado: (2020)

Oral Contraceptive Steroids Promote Papillary Thyroid Cancer Metastasis by Targeting Angiogenesis and Epithelial-Mesenchymal Transition
por: Dehghan, Mohammad Hossein, et al.
Publicado: (2021)

Oridonin promotes endoplasmic reticulum stress via TP53-repressed TCF4 transactivation in colorectal cancer
por: Zhou, Fangyuan, et al.
Publicado: (2023)

Disabled-2 downregulation promotes epithelial-to-mesenchymal transition
por: Martin, J C, et al.
Publicado: (2010)

Preparation of oridonin nanocrystals and study of their endocytosis and transcytosis behaviours on MDCK polarized epithelial cells
por: Sheng, Huagang, et al.
Publicado: (2020)

Ribonucleotide reductase subunit M2 promotes proliferation and epithelial–mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma
por: Yang, Min, et al.
Publicado: (2021)

Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan
por: Alaaeldin, Rania, et al.
Publicado: (2022)

Expression of Concern: STEAP1 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway
Publicado: (2023)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition
por: Subbalakshmi, Ayalur Raghu, et al.
Publicado: (2023)

E-cadherin on epithelial–mesenchymal transition in thyroid cancer
por: Zhu, Xiaoyu, et al.
Publicado: (2021)

IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
por: Wu, Xiongyan, et al.
Publicado: (2017)

MiR-375 mitigates retinal angiogenesis by depressing the JAK2/STAT3 pathway
por: Gong, Ruowen, et al.
Publicado: (2022)

Hypoxia-Induced Activation of JAK/STAT3 Signaling Pathway Promotes Trophoblast Cell Viability and Angiogenesis in Preeclampsia
por: Xu, Chengfang, et al.
Publicado: (2017)

Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas
por: Colomiere, M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_vc6qlu7pme72cstocn5bceq97g